However, the same pathway was not significantly enriched in CBFA2T3::GLIS2 fusion-negative M6/M7 AML samples versus fusion-negative non-M6/M7 AML samples (n = 14) (Supplemental Fig. 3C). This evidence concerns the gene GLIS2 and acute myeloid leukemia.